Advertisement

Topics

FDA grants accelerated approval to Lilly's soft tissue sarcoma drug

11:21 EDT 19 Oct 2016 | Reuters

(Reuters) - The U.S. Food and Drug Administration on Wednesday granted accelerated approval to Eli Lilly and Co's drug for treating adults with advanced soft tissue sarcoma (STS).

Original Article: FDA grants accelerated approval to Lilly's soft tissue sarcoma drug

NEXT ARTICLE

More From BioPortfolio on "FDA grants accelerated approval to Lilly's soft tissue sarcoma drug"

Quick Search
Advertisement
 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...